Crossmark

Development and validation of the RQLQ: a Raynaud’s disease–specific measure of health-related quality of life

Published Online: 2024-10-11

Published Print: 2024-12

Authors

Fábián, Balázs https://orcid.org/0000-0002-1073-568X
Csiki, Zoltán

Bugán, Antal
Funding

Funding for this research was provided by:

University of Debrecen
License Information

Text and Data Mining valid from 2024-10-11

Version of Record valid from 2024-10-11
More Information

Article History

Received: 14 June 2024

Revised: 27 August 2024

Accepted: 3 October 2024

First Online: 11 October 2024

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki and approved by the University of Debrecen Clinical Centre’s Regional and Institutional Ethics Committee and the Scientific (registration number, RKEB/IKEB 4822–2017).

: Informed consent was obtained from all subjects involved in the study.

: None.

Document is current